Results 161 to 170 of about 10,571,700 (283)
Introduction to Quarterly Progress Report
Contains cover page and an introduction.This report, the fourteenth in a series of quarterly progress reports issued by the Research Laboratory of Electronics, contains a review of the research activities of the Laboratory during the three-month period ...
Hill, Albert G., Wiesner, Jerome B.
core
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Establishment of clinical exercise physiology as a regulated healthcare profession in the UK: a progress report. [PDF]
Jones H +18 more
europepmc +1 more source
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Work-in-progress report: a prospective, multi-institutional observational study on intraoperative lymph node dissection for thymic epithelial malignancies with radiologically invasive features. [PDF]
Hamaji M +16 more
europepmc +1 more source
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
The Dutch Idiopathic Ventricular Fibrillation Registry: progress report on the quest to identify the unidentifiable. [PDF]
Verheul LM +8 more
europepmc +1 more source
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
Progress report on the single transducer ultrasonic thermometer using electrostatic actuator. [PDF]
Voldán M, Husník L, Mahovský D.
europepmc +1 more source
Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report. [PDF]
Washburn J, Millington DS.
europepmc +1 more source

